Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Epidemiological data regarding Oropouche virus across the specified regions

From: Addressing the emerging threat of Oropouche virus: implications and public health responses for healthcare systems

Region/Country

Key Findings

Brazil

- Epidemiological Notice: 199 confirmed cases (29.5%) from 675 samples in Amazonas (Jan 6, 2024). Most cases in Manaus (94.9%).

- Total Cases (2023–2024): 1,066 cases in Amazonas, with 699 from Manaus.

- Deaths: 2 reported in Bahia (first in Brazil/Americas), with severe coagulopathy as likely cause.

Plurinational State of Bolivia

- Confirmed Cases (Jan-Jul 2024): 356 cases in La Paz, Beni, Pando.

- Demographics: Half female, highest in the 30–39 age group.

- Co-infection: 5 cases with dengue reported. No deaths recorded.

Colombia

- Historical Cases (2019–2021): 87 cases in Leticia, Cúcuta, Cali, Villavicencio.

- Confirmed Cases (Jan-Jul 2024): 74 cases (largest in the 10–19 age group, majority female). No fatalities.

French Guiana

- First Case Reported: Sept 30, 2020.

- Confirmed Cases: 7 laboratory-confirmed cases in Saül, identified through high dengue-like disease incidences.

Peru

- Reported Cases (2016–2022): 94 cases in 6 departments.

- Peak Year: 2016 with 45% of cases.

Cuba

- Epidemic Declared: May 27, 2024.

- Confirmed Cases: 74 cases (Cienfuegos: 20, Santiago de Cuba: 54). Majority of cases in the 15–19 age group; no deaths recorded.